Welcome Guest
Sign In
Register
Home
Analytical Testing
Clinical Trials
Contract Research
Logistics
Manufacturing
Articles
Facility Tours
News
Events
Videos
Clinical Trials Documentary
A Solid Dosage Future Documentary
Whitepapers/App Notes
Issue Archives
Company Focus
Service Directory
Register
Sign In
Home
Cold Chain
Product and Service Directory
Clinical Trial Development Services and Outsourcing
Contract Research Organizations / Contract Research Services (CRO Services)
Preclinical Contract Research / Preclinical Research Services (Preclinical CRO)
Preclinical Pharmacology Services
Preclinical Pharmacology Services
Preclinical Pharmacology Services
Preclinical Drug Efficacy Testing and Modeling Services
Preclinical Pharmaceutical Screening Services
Preclinical Pharmacology Services by Therapy Type
Preclinical Cancer Pharmacology / Oncology Pharmacology Services
Preclinical Cardiovascular Pharmacology Services
Preclinical Diabetes Pharmacology Services
Preclinical Inflammation Pharmacology Services
Preclinical Multiple Sclerosis Pharmacology Services
News
Evonik Invests $109 Million in Vancouver Lipid Drug Facility
Tuesday, September 01, 2026
Evonik will invest more than 150 million Canadian dollars, or about $109 million, to build a new good manufacturing practice drug-product facility in Vancouver, Canada, expanding its capacity for lipid-based drug delivery products including vaccines, therapeutics and other advanced medicines.
read more
Andelyn to Scale Manufacturing for Genprex Diabetes Gene Therapy
Tuesday, September 01, 2026
Andelyn Biosciences has been selected by Genprex Inc. to support manufacturing scale-up for an adeno-associated virus-based gene therapy program being developed for Type 1 and Type 2 diabetes.
read more
Samsung Biologics Launches $1.83 Billion Tender Offer for PolyPeptide
Tuesday, September 01, 2026
Samsung Biologics has published the formal prospectus for its planned acquisition of PolyPeptide Group AG, offering about $55.70 in cash per share in a transaction that values the Swiss peptide manufacturer’s equity at approximately $1.83 billion.
read more
CPHI Milan Pharma Awards 2026 Finalists Announced
Tuesday, September 01, 2026
Informa Markets has announced the finalists for the CPHI Pharma Awards 2026, recognizing outstanding achievements across companies and individuals pushing the boundaries of science and technology to advance global healthcare.
read more
When commercialization doesn't follow a standard playbook
Monday, August 31, 2026
Low-volume launches. Complex combination products. Market-specific requirements. Unpredictable demand. Commercialization challenges are different for every program, yet many outsourcing models are built for standardization, not flexibility.
Discover how Ensera helps pharmaceutical companies ...
read more
More News
Featured Videos
Disabled_Documentary: A Solid Dosage Future
In the pharmaceutical manufacturing space, while biopharmaceuticals often dominate discussions, it's crucial to acknowledge the enduring significance of solid dosage products (e.g., tablets, capsules, pills). These traditional forms remain the ...
A Solid Dosage Future
In the pharmaceutical manufacturing space, while biopharmaceuticals often dominate discussions, it's crucial to acknowledge the enduring significance of solid dosage products (e.g., tablets, capsules, pills). These traditional forms remain the ...
More Videos
Featured Products and Services
We're sorry, no matching articles were found. Please select different filter options and try your search again.
More Featured Products
Featured Articles
We're sorry, no matching articles were found. Please select different filter options and try your search again.
Subscriptions
Get started here for your complimentary print or digital subscription
Sign up Now »